Last reviewed · How we verify
NCT05820308: POOCH
Companion Dog Walking for ICU Survivor Health
NA trial testing Companion Dog Walking in Post Intensive Care Syndrome in 6 participants. Completed in 1 May 2024.
1 May 2024
Quick facts
| Lead sponsor | University of Missouri, Kansas City |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 6 |
| Start date | 15 May 2023 |
| Primary completion | 1 May 2024 |
| Estimated completion | 1 May 2024 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Companion Dog Walking
- Attention Control Group
Conditions studied
- Post Intensive Care Syndrome — all drugs for Post Intensive Care Syndrome →
- Depression — all drugs for Depression →
- Anxiety — all drugs for Anxiety →
- Quality of Life — all drugs for Quality of Life →
Sponsor
University of Missouri, Kansas City
Who can join
18 and older, any sex, with Post Intensive Care Syndrome or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to determine the feasibility and acceptability of a randomized controlled trial comparing a pet dog walking intervention to an attention control education intervention in adult intensive care unit survivors. The main question\[s\] it aims to answer are: * What is the feasibility of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors. * What is the acceptability of a pet dog-walking intervention compared to an attention control education intervention on depression, anxiety, cortisol, and quality of life for adult ICU survivors. The secondary question\[s\] it aims to answer are: \- What are the differences in depression, anxiety, serum cortisol, and quality of life between and within a companion dog walking intervention compared to an attention control education intervention for ICU survivors? Participants in the intervention group will be asked to: * Participate in dog walking with their pet dog at least three times per week, for at least 10 minutes each walk, for 8-weeks. * Wear an activity monitor and record their dog walks in a diary. * Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8. * Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8. Participants in the control group will be asked to: * Read educational materials about their pet dog's health once every week (education materials are provided by the researchers). * Wear an activity monitor and record when they read their education materials in a diary. * Complete surveys to measure depression, anxiety, and quality of life at the start of the study, after week 4, and after week 8. * Have blood drawn to measure cortisol levels at the start of the study, after week 4, and after week 8. Participants will be assigned to an intervention group or a control group to see if there are differences in depression, anxiety, serum cortisol, and quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05820308
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post Intensive Care Syndrome
Currently open trials in the same condition.
- NCT05844579 — The ICU LIBERATION Study · recruiting
- NCT06310109 — Effect of Pediatric Intensive Care Unit Diaries on PICS-p · NA · recruiting
Other University of Missouri, Kansas City trials
Trials by the same sponsor.
- NCT06517628 — The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study · recruiting
- NCT04556227 — Simultaneous Recumbent Cycling and Cognitive Training · NA · recruiting
- NCT07450209 — COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II) · Phase 2 · active not recruiting
- NCT06374186 — Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes i · NA · completed
- NCT06133959 — Healthy ME: Advancing Health Equity in Lymphatic Pain and Lymphedema in Black and Hispanic Women With Breast Cancer · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05820308 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Missouri, Kansas City
- Last refreshed: 10 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05820308.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing